Science Advisors
Datacubed Health leverages the expertise of some of the most innovative minds in health, medicine and technology
The Science Advisor Board Panel includes: a creator of the MIT Media Lab, a former leader of the U.S. Human Genome Project, a former director of the U.S. National Institute of Mental Health, the designer of top-selling video games, a former Chief of Medicine at Massachusetts General Hospital, and a neurologist from a leading biotech company.
Alex “Sandy” Pentland, Ph.D.
Professor Alex ‘Sandy’ Pentland directs the MIT Connection Science and Human Dynamics labs and previously helped create and direct the MIT Media Lab and the Media Lab Asia in India. He is one of the most-cited scientists in the world, and Forbes recently declared him one of the “7 most powerful data scientists in the world” along with Google founders and the Chief Technical Officer of the United States. He has received numerous awards and prizes such as the McKinsey Award from Harvard Business Review, the 40th Anniversary of the Internet from DARPA, and the Brandeis Award for work in privacy.
He is a founding member of advisory boards for Google, AT&T, Nissan, and the UN Secretary General, a serial entrepreneur who has co-founded more than a dozen companies including social enterprises such as the Data Transparency Lab, the Harvard-ODI-MIT DataPop Alliance and the Institute for Data Driven Design. He is a member of the U.S. National Academy of Engineering and leader within the World Economic Forum.
Together Sandy and his students have pioneered computational social science, organizational engineering, wearable computing (Google Glass), image understanding, and modern biometrics. His most recent books are Social Physics, published by Penguin Press, and Honest Signals, published by MIT Press.
Ari Patrinos, Ph.D.
Aristides Patrinos is Chief Scientist, Director of Research and Chair of the Science Advisory Board at Novim. Ari was previously Deputy Director, Research, NYU Center For Urban Science & Progress, Brooklyn, NY. Prior to that, he was President of Synthetic Genomics Inc., and Director of the Office of Biological and Environmental Research in the Department of Energy’s Office of Science, where he oversaw human and microbial genome research, structural biology, nuclear medicine and health effects and global climate change. His accomplishments include the launch and management of DOE’s portion of the U.S. Global Change Research Program and his contributions to the international effort known as the Human Genome Project (HGP). Under his leadership, DOE contributed a significant part of the first complete sequence of the human genome. Dr. Patrinos also created the DOE Joint Genome Institute and launched the Genomes to Life program.
Prior to DOE, he carried out research projects in environmental science and in engineering at both Brookhaven and Oak Ridge National Laboratories. He was an Assistant Professor at the University of Rochester after receiving his Ph.D. in Mechanical Engineering and Astronautical Sciences from Northwestern University. Dr. Patrinos received his degree in Mechanical and Electrical Engineering from the National Technical University of Athens in 1970.
A member and fellow of five professional societies, he has served on several committees of the National Academy of Sciences and is the recipient of three Presidential Rank Awards and two Secretary of Energy Gold Medals.
Steve Hyman, M.D.
Steven Hyman is director of the Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard, a core member of the Broad, and Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Dr. Hyman previously served as provost of Harvard University for ten years and also served as director of the U.S. National Institute of Mental Health (NIMH), where he emphasized investment in neuroscience and emerging genetic technologies. Dr. Hyman is president of the American College of Neuropsychopharmacology, past president of the Society for Neuroscience, and founding president of the International Neuroethics Society, as well as previously having served as editor of the Annual Review of Neuroscience. He is a member of the U.S. National Academy of Medicine where he serves on the council. He chairs the Forum on Neuroscience and Nervous System Disorders of the National Academies of Sciences, Engineering, and Medicine (NASEM) and serves on the governing board of the National Research Council, the operating arm of NASEM. Hyman is a fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science, and he is a Distinguished Life Fellow of the American Psychiatric Association.
Hyman received his B.A. summa cum laude from Yale College, an M.A. from the University of Cambridge, and an M.D. cum laude from Harvard Medical School.
Nicholas Fortugno
Nick Fortugno is a game designer, gamification expert and entrepreneur. He is Chief Creative Officer of Playmatics, a company that creates highly-engaging games, media, user experiences, and applications on the internet, social media networks, and a variety of connected platforms. Previously, Nick was the Director of Game Design at gameLab, where he was a designer, writer and project manager on dozens of commercial and serious games, and served as lead designer on the blockbuster Diner Dash and the award-winning serious game Ayiti: The Cost of Life. He was also the co-founder and Chief Creative Officer of Rebel Monkey, a NYC online games company. Nick teaches game design and interactive narrative design at Parsons School of Design, and has participated in the construction of the school’s game design curriculum. Nick is also a co-founder of the Come Out and Play street games festival hosted in New York City and Amsterdam.
Fortugno double majored in both English and Philosophy at the State University of New York College at Purchase and later earned his MFA from Parsons.
Dennis Ausiello, M.D.
Dennis Ausiello is the Jackson Professor of Clinical Medicine at Harvard Medical School, and formerly Chief of Medicine at Massachusetts General Hospital. A nationally recognized leader in academic medicine, Ausiello was elected to the Institute of Medicine of the National Academy of Science and the American Academy of Arts and Sciences. He has made substantial contributions to the field of epithelial biology in the areas of membrane protein trafficking, ion channel regulation and signal transduction. He has published numerous articles, book chapters and textbooks and currently serves as the co-editor of The Cecil Textbook of Medicine, now in its 23rd edition. He has written for The New York Times, The Wall Street Journal and The Boston Globe on subjects including human genetics, clinical trials and the relationship between the academy and industry. Ausiello has been the recipient of two MERIT awards from the National Institutes of Health and has served as a counsel member of the National Institute of Diabetes, Digestive and Kidney Diseases Advisory Council and the National Advisory Council on Aging.
He received his undergraduate degree from Harvard College and his medical degree from the University of Pennsylvania.
David Margolin, M.D., Ph.D.
Dr. David H. Margolin, M.D., Ph.D., is the Senior Vice President of Clinical & Translational Medicine at Cerevance and a board-certified neurologist with additional expertise in cell and molecular immunology. Prior to joining Cerevance, Dr. Margolin previously served in several leadership roles at Sanofi-Genzyme over a 14-year period. He leveraged his expertise in designing and leading translational medicine initiatives, as well as clinical trials from phase 1 to phase 4 across various neurologic and rare disease indications, spanning biologics, small molecules and cell and gene therapies. Dr. Margolin served on the faculty in neurology at Harvard Medical School for 15 years, has authored more than 30 publications in peer-reviewed journals including The Lancet, New England Journal of Medicine, Brain, Blood and Neurology, as well as being the inventor of several patents. Dr. Margolin also serves as a Member of the Advisory Board at BlueStar Capital Management.
Dr. Margolin obtained his bachelor’s degree from Harvard College magna cum laude and his M.D. and Ph.D. degrees from the University of Pennsylvania.
